OMX30 1 513 -0,6%  OMXH25 3 668 -0,5%  OMXC20 898 0,0%  Dow 19 886 0,0%  Nas 5 060 0,4%  EUR 9,4930 0,1%  USD 8,9565 0,2%  Olja 55,7 0,1%  Guld 1 213 1,3% 

Abbott Laboratories Aktie

40,92USD 0,21USD 0,52%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Abbott Laboratories

2015 2016e 2017e 2018e 2019e
Utdelning 0,96 1,04 1,09 1,15 1,23
Direktavkastning (i %) 2,12 2,60 2,74 2,89 3,08
PE-tal 21,10 18,09 16,39 14,73 13,28
Resultat/aktie 2,15 2,20 2,43 2,71 3,00
ytterligare nyheter

Analyser om Abbott Laboratories

ytterligare analyser

Abbott Laboratories Peer Group

Abbott Laboratories 40,92
0,5%
Alexion Pharmaceuticals 136,81
-0,4%
AstraZeneca 501,50
-1,3%
BB BIOTECH 55,10
-2,1%
Bayer 101,10
-0,5%
Biotest 16,95
-1,1%
Celgene 117,47
0,3%
Fresenius Medical Care 76,47
0,2%
Fresenius 74,05
1,0%
GlaxoSmithKline 15,81
-0,3%
Johnson & Johnson 114,60
0,0%
Merck 62,33
0,2%
Merck 101,95
-1,6%
Novartis 72,10
-1,2%
Pfizer 32,51
-0,3%
Roche 240,30
-1,3%
STADA Arzneimittel 48,33
-1,0%
Sanofi 76,81
-1,6%
Vertex Pharmaceuticals 83,16
1,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Abbott Laboratories

till bolagsprofilen
Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products. It operates through four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The Established Pharmaceutical Products segment includes branded generic pharmaceuticals manufactured, marketed and sold outside the United States and are generally sold directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its owned distribution centers and public warehouses, depending on the market served. The Diagnostic Products segment covers diagnostic systems and tests manufactured, marketed, and sold worldwide to blood banks, hospitals, commercial laboratories, clinics, physicians' offices, government agencies, alternate-care testing sites, and plasma protein therapeutic companies. The segment's products are generally marketed and sold directly from Abbott-owned distribution centers, public warehouses and third-party distributors. The Nutritional Products segment includes pediatric and adult nutritional products manufactured, marketed, and sold worldwide. Its products are generally marketed and sold directly to customers and to institutions, wholesalers, retailers, health care facilities, government agencies, and third-party distributors from owned distribution centers or third-party distributors. The Vascular Products segment includes coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease manufactured, marketed and sold worldwide. The segment's products are generally marketed and sold directly to hospitals from Abbott-owned distribution centers and public warehouses. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Realtidskurs Abbott Laboratories

Bid
40,92
USD
Ask
40,93
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Abbott Laboratories i USDPUSH CHART

Kurs 40,92 USD 0,21 0,52 %
Kurstid 21:59:57
Datum 13.01.2017
Öppning 40,73
Gårdagen 40,92
Dagshögsta 41,35
Dagslägsta 40,69
52 v. högsta 45,79
52 v. lägsta 36,00
52 v. perf.
Volym (Antal) 622 439
Börsvärde (SEK) 622,02 Mrd
Börsen
Kurs för 40,92 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 366,50 SEK.

Till aktien Abbott Laboratories

Ticker
ISIN US0028241000
Index BX Swiss - USA, S&P 100, NYSE US 100, NASDAQ Comp., S&P 500

Abbott Laboratories Nyckeltal

Börsvärde i SEK 622,02 Mrd
Free float % 99,49
Antal aktier mio. 1 726,20
Cashflow/aktie i lokal valuta 2,70
Bokvärde/aktie i lokal valuta 14,33
60 dagar vola 23,42
PBV 3,17

Abbott Laboratories Historiska kurser

2017-01-13 40,92 622 439
2017-01-12 40,71 504 862
2017-01-11 41,09 705 535
2017-01-10 41,28 673 063
2017-01-09 40,75 618 299